{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:43:19Z","timestamp":1787766199695,"version":"build-2784847793"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cpt.2023.12.001","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T17:05:18Z","timestamp":1702141518000},"page":"212-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Coexistence of myeloproliferative neoplasms with multiple myeloma"],"prefix":"10.1016","volume":"2","author":[{"given":"Qiuqing","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minqiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2923-6880","authenticated-orcid":false,"given":"Li","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2023.12.001_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ajh.26751","article-title":"The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms","volume":"98","author":"Thiele","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cpt.2023.12.001_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cpt.2023.12.001_bib3","doi-asserted-by":"crossref","first-page":"970","DOI":"10.7326\/0003-4819-78-6-970","article-title":"Thrombocytosis in multiple myeloma","volume":"78","author":"Zimelman","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpt.2023.12.001_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5045\/br.2013.48.3.228","article-title":"Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis","volume":"48","author":"Niscola","year":"2013","journal-title":"Blood Res"},{"key":"10.1016\/j.cpt.2023.12.001_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1213942","article-title":"Case Report: effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy","volume":"13","author":"Krishnan","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.cpt.2023.12.001_bib6","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.2147\/JIR.S428977","article-title":"Concurrent polycythemia vera with newly diagnosed multiple myeloma: case report and literature review","volume":"16","author":"Yuan","year":"2023","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.cpt.2023.12.001_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.clml.2011.04.001","article-title":"Essential thrombocythemia and multiple myeloma: two rare diseases in one patient","volume":"11","author":"Eskazan","year":"2011","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.cpt.2023.12.001_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1243997","article-title":"Molecular and immunological mechanisms of clonal evolution in multiple myeloma","volume":"14","author":"Forster","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cpt.2023.12.001_bib9","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","article-title":"Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis","volume":"98","author":"Kaser","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cpt.2023.12.001_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2141.2000.02188.x","article-title":"Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial","volume":"110","author":"Finazzi","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cpt.2023.12.001_bib11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1365-2141.2002.3346_1.x","article-title":"Second malignancies in patients with essential thrombocythaemia","volume":"116","author":"Randi","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cpt.2023.12.001_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/bmt.2010.157","article-title":"Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant","volume":"46","author":"Holtan","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cpt.2023.12.001_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/bmt.2013.117","article-title":"High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation","volume":"49","author":"Nishihori","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cpt.2023.12.001_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.seminoncol.2022.01.005","article-title":"Pathogenic signaling in multiple myeloma","volume":"49","author":"Bolomsky","year":"2022","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cpt.2023.12.001_bib15","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/hon.3066","article-title":"A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed\/refractory multiple myeloma patients","volume":"40","author":"Berenson","year":"2022","journal-title":"Hematol Oncol"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713223001040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713223001040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T06:33:55Z","timestamp":1729060435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713223001040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2949713223001040"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2023.12.001","relation":{},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coexistence of myeloproliferative neoplasms with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}